-
Innovation Ranking
NewInnovation Ranking – Spectrum Pharmaceuticals Inc
Spectrum Pharmaceuticals Inc (Spectrum) is a biopharma company that acquires, develops, and commercializes novel drug candidates for treatment of cancer. The company’s pipeline products include ROLONTIS, for treatment of chemotherapy-induced neutropenia helps to reduce the frequency of multiplication of tumors. This product is in phase 3 trails.; Poziotinib, an irreversible tyrosine kinase inhibitor, for non-small cell lung cancer (NSCLC) tumors with various mutations. This product is in phase 2 trials and lead candidate for the organization. The company has R&D...
-
Innovation Ranking
NewInnovation Ranking – Spectrum Brands Holdings Inc
Spectrum Brands Holdings Inc (SBH) is a manufacturer and marketer of consumer products and home essentials. The company manufactures, distributes, and supplies specialty pet supplies, personal care products, small household appliances, and home pest control products, personal insect repellents, and cleaning products. SBH markets products through trade channels, including retailers, wholesalers, and distributors, warehouse clubs, food and drug chains, pet superstores, and construction companies. It markets products under the Eukanuba, Healthy-Hide, DreamBone, SmartBones, Hot Shot, Black Flag, Real-Kill, Rejuvenate, Russell...
-
Product Insights
NewLikelihood of Approval Analysis for Autism Spectrum Disorder (ASD)
Overview How likely is it that the drugs in Autism Spectrum Disorder (ASD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Autism Spectrum Disorder (ASD) Overview Autism Spectrum Disorder (ASD) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Autism Spectrum Disorder (ASD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TNX-1900 in Autism Spectrum Disorder (ASD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Autism Spectrum Disorder (ASD) Drug Details: Oxytocin (TI-001)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MM-402 in Autism Spectrum Disorder (ASD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MM-402 in Autism Spectrum Disorder (ASD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MM-402 in Autism Spectrum Disorder (ASD) Drug Details: Midomafetamine (MM-402)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ARD-501 in Autism Spectrum Disorder (ASD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ARD-501 in Autism Spectrum Disorder (ASD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ARD-501 in Autism Spectrum Disorder (ASD) Drug Details: ARD-501 is...
-
Product Insights
Autism Spectrum Disorder (ASD) – Drugs In Development, 2023
Global Markets Direct’s, ‘Autism Spectrum Disorder (ASD) - Drugs In Development, 2023’, provides an overview of the Autism Spectrum Disorder (ASD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Autism Spectrum Disorder (ASD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Autism Spectrum Disorder (ASD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Autism Spectrum Disorder (ASD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Autism Spectrum Disorder (ASD) Drug Details: Psilocybin is...